These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2893855)

  • 1. Effects of bunitrolol on adrenergic and serotonergic receptors.
    Tsuchihashi H; Aono J; Nagatomo T; Kawada T; Ohta H; Imai S
    Jpn J Pharmacol; 1987 Nov; 45(3):349-56. PubMed ID: 2893855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
    Tsuchihashi H; Nagatomo T
    J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCI-9042: high affinity for serotonergic receptors as assessed by radioligand binding assay.
    Maruyama K; Kinami J; Sugita Y; Takada Y; Sugiyama E; Tsuchihashi H; Nagatomo T
    J Pharmacobiodyn; 1991 Apr; 14(4):177-81. PubMed ID: 1682438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro.
    Ruffolo RR; Messick K; Horng JS
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):317-26. PubMed ID: 6090958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the alpha-adrenoceptors mediating positive inotropy of rat left atria by use of selective agonists and antagonists.
    Williamson KL; Broadley KJ
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):181-98. PubMed ID: 2883945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of bunitrolol for beta 1- and beta 2-adrenergic receptors and 5HT1B-receptors: assessment by biphasic Scatchard plots and biphasic displacement curve analysis with 125I-iodocyanopindolol and 3H-CGP12177.
    Tsuchihashi H; Nagotomo T; Imai S
    Jpn J Pharmacol; 1989 Jun; 50(2):93-100. PubMed ID: 2570175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
    Chiu CC; Lin YT; Tsai CH; Liang JC; Chiang LC; Wu JR; Chen IJ; Yeh JL
    Gen Pharmacol; 2000 Jun; 34(6):391-400. PubMed ID: 11483288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-receptor blocking potencies of the three newly synthesized beta-adrenergic antagonists (S-596, K-351, N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase.
    Nagatomo T; Tsuchihashi H; Sasaki M; Nakagawa Y; Nakahara H; Imai S
    Jpn J Pharmacol; 1984 Feb; 34(2):249-54. PubMed ID: 6205196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the apparent irreversible beta-adrenoceptor antagonist Ro 03-7894 with propranolol in cardiac ventricular muscle by pharmacological and radioligand binding techniques.
    Rankin A; Broadley KJ
    Biochem Pharmacol; 1982 Apr; 31(7):1325-32. PubMed ID: 6124256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone-dependent interconversion of myocardial alpha- and beta-adrenoceptors in the rat.
    Kunos G
    Br J Pharmacol; 1977 Jan; 59(1):177-89. PubMed ID: 836997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?
    Williamson KL; Broadley KJ
    Br J Pharmacol; 1989 Oct; 98(2):597-611. PubMed ID: 2555016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
    Huang YC; Wu BN; Lin YT; Chen SJ; Chiu CC; Cheng CJ; Chen IJ
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):10-20. PubMed ID: 10413061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens.
    Ko FN; Yu SM; Su MJ; Wu YC; Teng CM
    Br J Pharmacol; 1993 Oct; 110(2):882-8. PubMed ID: 7902181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of choice of agonist in studies designed to predict beta 2 : beta 1 adrenoceptor selectivity of antagonists from pA2 values on guinea-pig trachea and atria.
    O'Donnell SR; Wanstall JC
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):183-90. PubMed ID: 41190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.